A strategic conflict between two sides: host immune cells vs. viral symbiont of Leishmania spp. in cutaneous Leishmaniasis
DOI:
https://doi.org/10.34119/bjhrv8n2-385Keywords:
Leishmaniasis, Leishmaniavirus, immune cells, immunological response, tegumentary leishmaniasisAbstract
Leishmaniasis comprises a group of neglected tropical diseases that primarily affect regions in the Americas, the Mediterranean basin, the Middle East and central Asia, according to the World Health Organization (WHO). Although treatment options are available, leishmaniasis remains far from being considered a controlled disease. It has a complex immunological profile, involving components that act at different stages of disease progression. These include immune cells, skin (integumentary) cells, cytokines, and chemokines, each contributing to the pathology to varying degrees. The immune response is the primary mechanism for combating Leishmania parasites and plays a fundamental role in disease control. Moreover, the symbiotic relationship between the etiological agent of leishmaniasis and the Leishmania RNA virus (LRV) represents an additional risk factor for disease exacerbation. This relationship introduces yet another challenge for the host immune system, increasing susceptibility during the course of infection. The impact of LRV on the immune response in leishmaniasis is still not completely understood, as its role in modulating immune cell functions and soluble mediators are still under investigation. In this review, we aim to consolidate current knowledge and identify possible targets for future research. We will focus specifically on the immunological aspects of cutaneous leishmaniasis, with an emphasis on adaptive immune cells that are crucial in responding to reinfection.
References
Adaui, V., Lye, L. F., Akopyants, N. S., Zimic, M., Llanos-Cuentas, A., Garcia, L., Maes, I., De Doncker, S., Dobson, D. E., Arevalo, J., Dujardin, J. C., & Beverley, S. M. (2016).
Association of the endobiont double-stranded RNA virus LRV1 with treatment failure for human leishmaniasis caused by leishmania braziliensis in Peru and Bolivia. Journal of Infectious Diseases, 213(1), 112–121. https://doi.org/10.1093/infdis/jiv354
Alemayehu, B., & Alemayehu, M. (2017). Leishmaniasis: A Review on Parasite, Vector and Reservoir Host. Health Science Journal, 11(4), 1–6. https://doi.org/10.21767/1791-809x.1000519
Almeida, F. S., Vanderley, S. E. R., Comberlang, F. C., Andrade, A. G. de, Cavalcante-Silva, L. H. A., Silva, E. dos S., Palmeira, P. H. de S., Amaral, I. P. G. do, & Keesen, T. S. L. (2023). Leishmaniasis: Immune Cells Crosstalk in Macrophage Polarization. In Tropical Medicine and Infectious Disease (Vol. 8, Issue 5). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/tropicalmed8050276
Antonia, A. L., Gibbs, K. D., Trahair, E. D., Pittman, K. J., Martin, A. T., Schott, B. H., Smith, J. S., Rajagopal, S., Thompson, J. W., Reinhardt, R. L., & Ko, D. C. (2019). Pathogen Evasion of Chemokine Response Through Suppression of CXCL10. Frontiers in Cellular and Infection Microbiology, 9. https://doi.org/10.3389/fcimb.2019.00280
Antonio, L. de F., Lyra, M. R., Saheki, M. N., Schubach, A. de O., Miranda, L. de F. C., Madeira, M. de F., Lourenço, M. C. da S., Fagundes, A., Ribeiro, É. A. dos S., Barreto, L., & Pimentel, M. I. F. (2017). Effect of secondary infection on epithelialisation and total healing of cutaneous leishmaniasis lesions. Memorias Do Instituto Oswaldo Cruz, 112(9), 640–646. https://doi.org/10.1590/0074-02760160557
Atayde, V. D., da Silva Lira Filho, A., Chaparro, V., Zimmermann, A., Martel, C., Jaramillo, M., & Olivier, M. (2019). Exploitation of the Leishmania exosomal pathway by Leishmania RNA virus 1. Nature Microbiology, 4(4), 714–723. https://doi.org/10.1038/s41564-018-0352-y
Baeke, F., Takiishi, T., Korf, H., Gysemans, C., & Mathieu, C. (2010). Vitamin D: Modulator of the immune system. In Current Opinion in Pharmacology (Vol. 10, Issue 4, pp. 482–496). https://doi.org/10.1016/j.coph.2010.04.001
Bahrami, F., Harandi, A. M., & Rafati, S. (2018). Biomarkers of cutaneous leishmaniasis. Frontiers in Cellular and Infection Microbiology, 8(JUN), 1–8. https://doi.org/10.3389/fcimb.2018.00222
Bekkar, A., Isorce, N., Snäkä, T., Claudinot, S., Desponds, C., Kopelyanskiy, D., Prével, F., Reverte, M., Xenarios, I., Fasel, N., & Teixeira, F. (2022). Dissection of the macrophage response towards infection by the Leishmania-viral endosymbiont duo and dynamics of the type I interferon response. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.941888
Birnbaum, R., & Craft, N. (2011). Innate immunity and leishmania vaccination strategies. Dermatologic Clinics, 29(1), 89–102. https://doi.org/10.1016/j.det.2010.08.014
Bourreau, E., Ginouves, M., Prévot, G., Hartley, M. A., Gangneux, J. P., Robert-Gangneux, F., Dufour, J., Sainte-Marie, D., Bertolotti, A., Pratlong, F., Martin, R., Schütz, F., Couppié, P., Fasel, N., & Ronet, C. (2016). Presence of leishmania RNA virus 1 in leishmania guyanensis increases the risk of first-line treatment failure and symptomatic relapse. Journal of Infectious Diseases, 213(1), 105–111. https://doi.org/10.1093/infdis/jiv355
Brettmann, E. A., Shaik, J. S., Zangger, H., Lye, L. F., Kuhlmann, F. M., Akopyants, N. S., Oschwald, D. M., Owens, K. L., Hickerson, S. M., Ronet, C., Fasel, N., & Beverley, S. M. (2016). Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response. Proceedings of the National Academy of Sciences of the United States of America, 113(43), 11998–12005. https://doi.org/10.1073/pnas.1615085113
Cantanhêde, L. M., da Silva Júnior, C. F., Ito, M. M., Felipin, K. P., Nicolete, R., Salcedo, J. M. V., Porrozzi, R., Cupolillo, E., & Ferreira, R. de G. M. (2015). Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients. PLoS Neglected Tropical Diseases, 9(9), 1–11. https://doi.org/10.1371/journal.pntd.0004079
Cantanhêde, L. M., Fernandes, F. G., Eduardo Melim Ferreira, G., Porrozzi, R., De Godoi Mattos Ferreira, R., & Cupolillo, E. (2018). New insights into the genetic diversity of Leishmania RNA Virus 1 and its species-specific relationship with Leishmania parasites. PLoS ONE, 13(6), 1–16. https://doi.org/10.1371/journal.pone.0198727
Carvalho, A. K., Carvalho, K., Passero, L. F. D., Sousa, M. G. T., Da Matta, V. L. R., Gomes, C. M. C., Corbett, C. E. P., Kallas, G. E., Silveira, F. T., & Laurenti, M. D. (2016).
Differential Recruitment of Dendritic Cells Subsets to Lymph Nodes Correlates with a Protective or Permissive T-Cell Response during Leishmania (Viannia) Braziliensis or Leishmania (Leishmania) Amazonensis Infection. Mediators of Inflammation, 2016. https://doi.org/10.1155/2016/7068287
Carvalho, L. P., Passos, S., Schriefer, A., & Carvalho, E. M. (2012). Protective and pathologic immune responses in human tegumentary leishmaniasis. Frontiers in Immunology, 3(OCT), 1–9. https://doi.org/10.3389/fimmu.2012.00301
Castiglioni, P., Hartley, M. A., Rossi, M., Prevel, F., Desponds, C., Utzschneider, D. T., Eren, R. O., Zangger, H., Brunner, L., Collin, N., Zehn, D., Kuhlmann, F. M., Beverley, S. M., Fasel, N., & Ronet, C. (2017). Exacerbated Leishmaniasis Caused by a Viral Endosymbiont can be Prevented by Immunization with Its Viral Capsid. PLoS Neglected Tropical Diseases, 11(1), 1–20. https://doi.org/10.1371/journal.pntd.0005240
Charlton, R. L., Rossi-Bergmann, B., Denny, P. W., & Steel, P. G. (2018). Repurposing as a strategy for the discovery of new anti-leishmanials: The-state-of-the-art. Parasitology, 145(2), 219–236. https://doi.org/10.1017/S0031182017000993
Charmoy, M., Hurrell, B. P., Romano, A., Lee, S. H., Ribeiro-Gomes, F., Riteau, N., Mayer-Barber, K., Tacchini-Cottier, F., & Sacks, D. L. (2016). The Nlrp3 inflammasome, IL-1β, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL/6 mice. European Journal of Immunology, 46(4), 897–911. https://doi.org/10.1002/eji.201546015
de Carvalho, R. V. H., Lima-Junior, D. S., da Silva, M. V. G., Dilucca, M., Rodrigues, T. S., Horta, C. V., Silva, A. L. N., da Silva, P. F., Frantz, F. G., Lorenzon, L. B., Souza, M. M., Almeida, F., Cantanhêde, L. M., Ferreira, R. de G. M., Cruz, A. K., & Zamboni, D. S. (2019). Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition. Nature Communications, 10(1). https://doi.org/10.1038/s41467-019-13356-2
de Carvalho, R. V. H., Lima-Júnior, D. S., de Oliveira, C. V., & Zamboni, D. S. (2021). Endosymbiotic RNA virus inhibits Leishmania-induced caspase-11 activation. IScience, 24(1). https://doi.org/10.1016/j.isci.2020.102004
Eberl, G., Colonna, M., Santo, J. P. D., & McKenzie, A. N. J. (2015). Innate lymphoid cells: A new paradigm in immunology. Science, 348(6237). https://doi.org/10.1126/science.aaa6566
Eren, R. O., Reverte, M., Rossi, M., Hartley, M.-A., Patrik Castiglioni Florence Prevel, R. M., Desponds, C., Lye, L.-F., Drexler, S. K., Reith, W., Beverley, S. M., Ronet, C., & Fasel, N. (2017). Mammalian Innate Immune Response to a Leishmania-Resident RNA Virus Increases Macrophage Survival to Promote Parasite Persistence. Physiology & Behavior, 176(1), 139–148. https://doi.org/10.1016/j.chom.2016.08.001.Mammalian
Feijó, D., Tibúrcio, R., Ampuero, M., Brodskyn, C., & Tavares, N. (2016). Dendritic cells and leishmania infection: Adding layers of complexity to a complex disease. Journal of Immunology Research, 2016. https://doi.org/10.1155/2016/3967436
Felipin, K. P., Paloschi, M. V., Silva, M. D. S., Ikenohuchi, Y. J., Santana, H. M., Setúbal, S. da S., Rego, C. M. A., Lopes, J. A., Boeno, C. N., Serrath, S. N., Medeiros, E. H. R. T. De, Pimentel, I. F., Oliveira, A. E. R., Cupolillo, E., Cantanhêde, L. M., Ferreira, R. de G. M., & Zuliani, J. P. (2024). Transcriptomics analysis highlights potential ways in human pathogenesis in Leishmania braziliensis infected with the viral endosymbiont LRV1. PLoS Neglected Tropical Diseases, 18(5). https://doi.org/10.1371/journal.pntd.0012126
Franken, L., Schiwon, M., & Kurts, C. (2016). Macrophages: Sentinels and regulators of the immune system. Cellular Microbiology, 18(4), 475–487. https://doi.org/10.1111/cmi.12580
Gerosa, F., Tommasi, M., Benati, C., Gandini, G., Libonati, M., Tridente, G., Carra, G., & Trinchieri, G. (1993). Differential effects of tyrosine kinase inhibition in cd69 antigen expression and lytic activity induced by riL-2, riL-12, and riFN-α in human NK cells. In Cellular Immunology (Vol. 150, Issue 2, pp. 382–390). https://doi.org/10.1006/cimm.1993.1206
Ginouvès, M., Simon, S., Bourreau, E., Lacoste, V., Ronet, C., Couppié, P., Nacher, M., Demar, M., & Prévot, G. (2016). Prevalence and distribution of leishmania RNA virus 1 in leishmania parasites from French Guiana. American Journal of Tropical Medicine and Hygiene, 94(1), 102–106. https://doi.org/10.4269/ajtmh.15-0419
Glennon-Alty, L., Moots, R. J., Edwards, S. W., & Wright, H. L. (2021). Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression. Clinical and Experimental Immunology, 203(2), 151–159. https://doi.org/10.1111/cei.13525
Gombart, A. F. (2009). The vitamin D-antimicrobial peptide pathway and its role in protection against infection. In Future Microbiology (Vol. 4, Issue 9, pp. 1151–1165). https://doi.org/10.2217/fmb.09.87
Grabowska, J., Lopez-Venegas, M. A., Affandi, A. J., & Den Haan, J. M. M. (2018). CD169+ macrophages capture and dendritic cells instruct: The interplay of the gatekeeper and the general of the immune system. In Frontiers in Immunology (Vol. 9, Issue OCT). Frontiers Media S.A. https://doi.org/10.3389/fimmu.2018.02472
Grybchuk, D., Kostygov, A. Y., Macedo, D. H., d’Avila-Levy, C. M., & Yurchenko, V. (2018). RNA viruses in trypanosomatid parasites: A historical overview. Memorias Do Instituto Oswaldo Cruz, 113(4), 1–7. https://doi.org/10.1590/0074-02760170487
Hartley, M. A., Bourreau, E., Rossi, M., Castiglioni, P., Eren, R. O., Prevel, F., Couppié, P., Hickerson, S. M., Launois, P., Beverley, S. M., Ronet, C., & Fasel, N. (2016).
Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A. PLoS Pathogens, 12(9), 1–19. https://doi.org/10.1371/journal.ppat.1005852
Hartley, M.-A., Ronet, C., Zangger, H., Beverley, S. M., & Fasel, N. (2012). Leishmania RNA virus: when the host pays the toll. Frontiers in Cellular and Infection Microbiology, 2(July), 99. https://doi.org/10.3389/fcimb.2012.00099
Hotez, P. J. (2013). NTDs V.2.0: “Blue Marble Health”-Neglected Tropical Disease Control and Elimination in a Shifting Health Policy Landscape. PLoS Neglected Tropical Diseases, 7(11). https://doi.org/10.1371/journal.pntd.0002570
Hotez, P. J., Damania, A., & Naghavi, M. (2016). Blue Marble Health and the Global Burden of Disease Study 2013. PLoS Neglected Tropical Diseases, 10(10), 6–11. https://doi.org/10.1371/journal.pntd.0004744
Italiani, P., Mosca, E., Camera, G. Della, Melillo, D., Migliorini, P., Milanesi, L., & Boraschi, D. (2020). Profiling the Course of Resolving vs . Persistent Inflammation in Human Monocytes : The Role of IL-1 Family Molecules. 11(July). https://doi.org/10.3389/fimmu.2020.01426
Ito, M. M., Catanhêde, L. M., Katsuragawa, T. H., da Silva Junior, C. F., Camargo, L. M. A., Mattos, R. de G., & Vilallobos-Salcedo, J. M. (2015). Correlation between presence of Leishmania RNA virus 1 and clinical characteristics of nasal mucosal leishmaniosis. Brazilian Journal of Otorhinolaryngology, 81(5), 533–540. https://doi.org/10.1016/j.bjorl.2015.07.014
Ives, A., Ronet, C., Prevel, F., Ruzzante, G., Fuertes-, S., Schutz, F., Zangger, H., Revaz-breton, M., Lye, L., Hickerson, S. M., Beverley, S. M., Acha-orbea, H., Launois, P., Fasel, N., & Masina, S. (2011). Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science, 331(6018), 775–778.
https://doi.org/10.1126/science.1199326.Leishmania
Kariyawasam, R., Grewal, J., Lau, R., Purssell, A., Valencia, B. M., Llanos-Cuentas, A., & Boggild, A. K. (2017). Influence of Leishmania RNA Virus 1 on Proinflammatory Biomarker Expression in a Human Macrophage Model of American Tegumentary Leishmaniasis. Journal of Infectious Diseases, 216(7), 877–886. https://doi.org/10.1093/infdis/jix416
Kariyawasam, R., Lau, R., Valencia, B. M., Llanos-Cuentas, A., & Boggild, A. K. (2020). Leishmania RNA Virus 1 (LRV-1) in leishmania (viannia) braziliensis isolates from Peru: A description of demographic and clinical correlates. American Journal of Tropical Medicine and Hygiene, 102(2), 280–285. https://doi.org/10.4269/ajtmh.19-0147
Kashem, S. W., Haniffa, M., & Kaplan, D. H. (2017). Antigen-Presenting Cells in the Skin. https://doi.org/10.1146/annurev-immunol
Komai-Koma, M., Li, D., Wang, E., Vaughan, D., & Xu, D. (2014). Anti-Toll-like receptor 2 and 4 antibodies suppress inflammatory response in mice. Immunology, 143(3), 354–362. https://doi.org/10.1111/imm.12312
Kopelyanskiy, D., Desponds, C., Prevel, F., Rossi, M., Migliorini, R., Snäkä, T., Eren, R. O., Claudinot, S., Lye, L. F., Pasparakis, M., Beverley, S. M., & Fasel, N. (2022). Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.944819
Lee, S. H., Charmoy, M., Romano, A., Paun, A., Chaves, M. M., Cope, F. O., Ralph, D. A., & Sacks, D. L. (2018). Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment. Journal of Experimental Medicine, 215(1), 357–375. https://doi.org/10.1084/jem.20171389
Liese, J., Schleicher, U., & Bogdan, C. (2008). The innate immune response against Leishmania parasites. Immunobiology, 213(3–4), 377–387. https://doi.org/10.1016/j.imbio.2007.12.005
Luz, Y., Rebouças, A., Bernardes, C. P. O. S., Rossi, E. A., Machado, T. S., Souza, B. S. F., Brodskyn, C. I., Veras, P. S. T., dos Santos, W. L. C., & de Menezes, J. P. B. (2023). Leishmania infection alters macrophage and dendritic cell migration in a three-dimensional environment. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1206049
Mace, E. M., Gunesch, J. T., Dixon, A., & Orange, J. S. (2016). Human NK cell development requires CD56-mediated motility and formation of the developmental synapse. Nature Communications, 7, 1–13. https://doi.org/10.1038/ncomms12171
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013). Macrophage plasticity and polarization in tissue repair and remodelling. Journal of Pathology, 229(2), 176–185. https://doi.org/10.1002/path.4133
Matte, C. (2021). Leishmania donovani Metacyclic Promastigotes Impair. 89(7), 1–14.
Messlinger, H., Sebald, H., Heger, L., Dudziak, D., Bogdan, C., & Schleicher, U. (2018).
Monocyte-derived signals activate human natural killer cells in response to Leishmania parasites. Frontiers in Immunology, 9(JAN). https://doi.org/10.3389/fimmu.2018.00024
Mirabedini, Z., Mirjalali, H., Kazemirad, E., Khamesipour, A., Samimirad, K., Koosha, M., Saberi, R., Rahimi, H. M., Mohebali, M., & Hajjaran, H. (2023). The effects of Leishmania RNA virus 2 (LRV2) on the virulence factors of L. major and pro-inflammatory biomarkers: an in vitro study on human monocyte cell line (THP-1). BMC Microbiology, 23(1). https://doi.org/10.1186/s12866-023-03140-0
Molfetta, R., Quatrini, L., Santoni, A., & Paolini, R. (2017). Regulation of NKG2D-dependent NK Cell functions: The Yin and the Yang of receptor endocytosis. In International Journal of Molecular Sciences (Vol. 18, Issue 8). MDPI AG. https://doi.org/10.3390/ijms18081677
Mukhopadhyay, D., Mukherjee, S., Roy, S., Dalton, J. E., Kundu, S., Sarkar, A., Das, N. K., Kaye, P. M., & Chatterjee, M. (2015). M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis. PLoS Neglected Tropical Diseases, 9(10). https://doi.org/10.1371/journal.pntd.0004145
Müller, A. J., Aeschlimann, S., Olekhnovitch, R., Dacher, M., Späth, G. F., & Bousso, P. (2013). Photoconvertible pathogen labeling reveals nitric oxide control of leishmania major infection in vivo via dampening of parasite metabolism. Cell Host and Microbe, 14(4), 460–467. https://doi.org/10.1016/j.chom.2013.09.008
Orikaza, C. M., Pessoa, C. C., Paladino, F. V, Florentino, P. T. V, Barbiéri, C. L., Goto, H., Ramos-Sanchez, E. M., Franco Da Silveira, J., Rabinovitch, M., Mortara, R. A., & Real, F. (2020). Dual Host-Intracellular Parasite Transcriptome of Enucleated Cells Hosting Leishmania amazonensis: Control of Half-Life of Host Cell Transcripts by the Parasite. https://doi.org/10.1128/IAI
Pan American Health Organization. (2019). Manual of procedures for surveillance and control of leishmaniasis in the Americas. In World Health Organization.
Papenfuss, T. L. (2017). Immunopathology in Toxicology and Drug Development. Immunopathology in Toxicology and Drug Development, 2, 601–618. https://doi.org/10.1007/978-3-319-47377-2
Regli, I. B., Passelli, K., Hurrell, B. P., & Tacchini-Cottier, F. (2017). Survival mechanisms used by some Leishmania species to escape neutrophil killing. Frontiers in Immunology, 8(NOV), 1–8. https://doi.org/10.3389/fimmu.2017.01558
Ribeiro, C. V., Rocha, B. F. B., Oliveira, E., Teixeira-Carvalho, A., Martins-Filho, O. A., Murta, S. M. F., & Peruhype-Magalhães, V. (2020). Leishmania infantum induces high phagocytic capacity and intracellular nitric oxide production by human proinflammatory monocyte. Memorias Do Instituto Oswaldo Cruz, 115(1), 1–10. https://doi.org/10.1590/0074-02760190408
Romano, A., Carneiro, M. B. H., Doria, N. A., Roma, E. H., Ribeiro-Gomes, F. L., Inbar, E., Lee, S. H., Mendez, J., Paun, A., Sacks, D. L., & Peters, N. C. (2017). Divergent roles for Ly6C+CCR2+CX3CR1+inflammatory monocytes during primary or secondary infection of the skin with the intra-phagosomal pathogen Leishmania major. PLoS Pathogens, 13(6), 1–26. https://doi.org/10.1371/journal.ppat.1006479
Roque, A. L. R., & Jansen, A. M. (2014). Wild and synanthropic reservoirs of Leishmania species in the Americas. International Journal for Parasitology: Parasites and Wildlife, 3(3), 251–262. https://doi.org/10.1016/j.ijppaw.2014.08.004
Rossi, M., Castiglioni, P., Hartley, M. A., Eren, R. O., Prével, F., Desponds, C., Utzschneider, D. T., Zehn, D., Cusi, M. G., Kuhlmann, F. M., Beverley, S. M., Ronet, C., & Fasel, N. (2017). Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis. Proceedings of the National Academy of Sciences of the United States of America, 114(19), 4987–4992. https://doi.org/10.1073/pnas.1621447114
Rossi, M., & Fasel, N. (2018). How to master the host immune system? Leishmania parasites have the solutions! International Immunology, 30(3), 103–111. https://doi.org/10.1093/intimm/dxx075
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., Abdollahpour, I., Abdulkader, R. S., Abebe, H. T., Abebe, M., Abebe, Z., Abejie, A. N., Abera, S. F., Abil, O. Z., Abraha, H. N., … Murray, C. J. L. (2018). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1736–1788. https://doi.org/10.1016/S0140-6736(18)32203-7
Ruiz-postigo, J. A., Jain, S., Ruiz-postigo, J. A., Jain, S., & Asia, E. (2021). Global leishmaniasis a baseline for the 2030 roadmap Surveillance mondiale de la leishmaniose : 2019-2020 , une période de référence pour la feuille de route à l ’ horizon 2030. 2019–2020.
Saberi, R., Fakhar, M., Mohebali, M., Anvari, D., & Gholami, S. (2019). Global status of synchronizing Leishmania RNA virus in Leishmania parasites: A systematic review with meta-analysis. Transboundary and Emerging Diseases, 66(6), 2244–2251. https://doi.org/10.1111/tbed.13316
Sacramento, L. A., Amorim, C. F., Campos, T. M., Saldanha, M., Arruda, S., Carvalho, L. P., Beiting, D. P., Carvalho, E. M., Novais, F. O., & Scott, P. (2023). NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis. PLoS Neglected Tropical Diseases, 17(8 August). https://doi.org/10.1371/journal.pntd.0011552
Saha, S., Mondal, S., Banerjee, A., Ghose, J., Bhowmick, S., & Ali, N. (2006). Immune responses in kala-azar. The Indian Journal of Medical Research, 123(3), 245–266.
Santamaria, J., Darrigues, J., van Meerwijk, J. P. M., & Romagnoli, P. (2018). Antigen-presenting cells and T-lymphocytes homing to the thymus shape T cell development. In Immunology Letters (Vol. 204, pp. 9–15). Elsevier B.V. https://doi.org/10.1016/j.imlet.2018.10.003
Stebut, E. Von, & Tenzer, S. (2017). International Journal of Medical Microbiology Cutaneous leishmaniasis : Distinct functions of dendritic cells and macrophages in the interaction of the host immune system with Leishmania major. International Journal of Medical Microbiology, September, 0–1. https://doi.org/10.1016/j.ijmm.2017.11.002
Stuart, K. D., Weeks, R., Guilbride, L., & Myler, P. J. (1992). Molecular organization of Leishmania RNA virus 1. Proceedings of the National Academy of Sciences of the United States of America, 89(18), 8596–8600. https://doi.org/10.1073/pnas.89.18.8596
Tarr, P. I., Aline, R. F., Smiley, B. L., Scholler, J., Keithly, J., & Stuart, K. (1988). LR1: A candidate RNA virus of Leishmania. Proceedings of the National Academy of Sciences of the United States of America, 85(24), 9572–9275. https://doi.org/10.1073/pnas.85.24.9572
Tomiotto-Pellissier, F., Bortoleti, B. T. da S., Assolini, J. P., Gonçalves, M. D., Carloto, A. C. M., Miranda-Sapla, M. M., Conchon-Costa, I., Bordignon, J., & Pavanelli, W. R. (2018).
Macrophage Polarization in Leishmaniasis: Broadening Horizons. Frontiers in Immunology, 9(October), 2529. https://doi.org/10.3389/fimmu.2018.02529
Valencia, B. M., Lau, R., Kariyawasam, R., Jara, M., Ramos, A. P., Chantry, M., Lana, J. T., Boggild, A. K., & Llanos-Cuentas, A. (2022). Leishmania RNA virus-1 is similarly detected among metastatic and non-metastatic phenotypes in a prospective cohort of American Tegumentary Leishmaniasis. In PLoS Neglected Tropical Diseases (Vol. 16, Issue 1). Public Library of Science. https://doi.org/10.1371/journal.pntd.0010162
Valigurová, A., & Kolářová, I. (2023). Unrevealing the Mystery of Latent Leishmaniasis: What Cells Can Host Leishmania? In Pathogens (Vol. 12, Issue 2). MDPI. https://doi.org/10.3390/pathogens12020246
Van Avondt, K., & Hartl, D. (2018). Mechanisms and disease relevance of neutrophil extracellular trap formation. European Journal of Clinical Investigation, 48(January), 1–10. https://doi.org/10.1111/eci.12919
Villani, A.-C., Sarkizova, S., & Hacohen, N. (2018). Systems Immunology: Learning the Rules of the Immune System. Annual Review of Immunology, 36(1), 813–842. https://doi.org/10.1146/annurev-immunol-042617-053035
Washington, D. C. (2024). Manual of procedures for leishmaniasis surveillance and control in the Region of the Americas. https://doi.org/10.37774/9789275127346
World Health Organization. (2021). No Title. Fact Sheets-Leishmaniasis. https://www.who.int/en/news-room/fact-sheets/detail/leishmaniasis
Xin, L., Li, Y., & Soong, L. (2007). Role of interleukin-1?? in activating the CD11chigh CD45RB- dendritic cell subset and priming Leishmania amazonensis- specific CD4+ T cells in vitro and in vivo. Infection and Immunity, 75(10), 5018–5026. https://doi.org/10.1128/IAI.00499-07
Yektaeian, N., Zare, S., Radfar, A. H., & Hatam, G. (2023). Superparamagnetic Iron Oxide-Labeled Leishmania major Can Be Traced in Fibroblasts. Journal of Parasitology Research, 2023. https://doi.org/10.1155/2023/7628912
